Eterna Therapeutics
ERNA
#10554
Rank
โ‚น0.68 B
Marketcap
โ‚น584.86
Share price
-6.18%
Change (1 day)
186.12%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น7,295. In 2022 the company made an earnings per share (EPS) of -โ‚น11,968 an increase over its 2021 EPS that were of -โ‚น79,071.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น11,968-84.86%
2021-โ‚น79,071

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น243.42-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น202.56-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น192.10-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.36-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น130.29-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น67.52-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA